End Stage Renal Disease Market Size, Share & Trends Analysis Report By Treatment (Transplant, Dialysis), By Region (APAC, North America, MEA, Europe, Latin America), And Segment Forecasts, 2023 - 2030

Research Methodology

A three-pronged approach was followed for deducing the end stage renal disease market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for end stage renal disease market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of end stage renal disease market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

End Stage Renal Disease Market Categorization:

The end stage renal disease market was categorized into four segments, namely treatment (Transplant, Dialysis), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The end stage renal disease market was segmented into treatment, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The end stage renal disease market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; U.K.; Germany; France; Italy; Spain; Denmark; Norway; Sweden; Japan; China; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

End stage renal disease market companies & financials:

The end stage renal disease market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• Nipro Corporation is a healthcare company that specializes in the development, manufacturing, and marketing of medical devices and pharmaceutical products globally. The company operates through three major segments: medical, pharmaceutical, and pharma packaging. The medical segment offers a product portfolio that includes artificial organ-related products, injections & infusions, dialysis-related medical equipment, and diabetes & generic drugs. Its pharmaceutical business segment involves the production and sale of pharmaceutical products, such as prefilled syringes, double bags, pharmaceutical contract manufacturing services, and drug delivery systems. Nipro Medical Corporation operates as a subsidiary of Nipro Corporation and develops products for renal interventional radiology, as well as surgical products to improve patient care.

• Fresenius Medical Care AG & Co. KGaA is a global healthcare company that engages in the development, manufacturing, and commercialization of lifesaving drugs & devices for clinical nutrition, infusion, and transfusion. The company operates as a wholly owned subsidiary of Fresenius SE & Co. KGaA. It functions across four reporting business units: Fresenius Kabi, Fresenius Medical Care, Fresenius Vamed, and Fresenius Helios. Fresenius Medical Care segment is the foremost developer and provider of products & services for people suffering from chronic kidney failure, which includes products such as hemodialysis machines, dialyzers & related disposable products. To date, it has provided dialysis treatments to more than 345,000 patients in around 150 countries throughout the world.          

• B. Braun Melsungen AG is a provider and manufacturer of healthcare products & medical care solutions. The company’s product portfolio consists of 5,000 products, with 95% of products being manufactured in-house. Hospital Care, Outpatient Market, Aesculap, and B. Braun Avitum are its key reportable segments. The company operates its business across therapies and indications, including ostomy care, continence care & urology, cardiothoracic surgery, diabetes care, general open surgery, extracorporeal blood treatment, infection prevention, pain therapy, infusion therapy, interventional vascular diagnostics & therapy, laparoscopic surgery, neurosurgery, nutrition therapy, orthopedic joint replacement, and wound management.

• BD focuses on the development, manufacture, and commercialization of a range of laboratory equipment, medical supplies, & diagnostic products. The company has three reportable segments: BD Medical, BD Interventional, and BD Life Sciences. Its products are used by healthcare institutions, researchers, clinical laboratories, and pharmaceutical companies. The BD Medical segment consists of various business units, including diabetes care, renal care, medication, procedural solutions, infection prevention, and pharmaceutical systems. The life sciences segment offers products and services for the collection & transport of diagnostics samples, instruments, & reagents to identify a range of healthcare-associated infections.    

• Baxter manufactures and distributes products & technologies related to infectious diseases, kidney disease, hemophilia, immune disorders, trauma, and other chronic & acute medical conditions. It offers products in various segments, such as pharmaceuticals, clinical nutrition, renal care, medication delivery, advanced surgery, and acute therapies. The company manufactures IV bags & related products for hospitals, which are used to deliver drugs & fluids, including parenteral nutrition, surgical care, and IV infusion pumps & administration kits. Its renal segment caters to the needs of individuals with kidney diseases and healthcare providers. Products offered by this segment include peritoneal dialysis, hemodialysis, and additional dialysis therapies & services. Baxter also specializes in medical devices, pharmacy automation, anesthetics, and bio-surgery & wound care solutions. The company has a global presence and operates primarily in the U.S., Asia Pacific, Europe, and the MEA.  

• Asahi Kasei Medical Co., Ltd. operates as a subsidiary of Asahi Kasei Corporation. The company engages in the development, manufacture, and sale of medical devices & therapeutics. It offers dialyzers (artificial kidneys) and related products, therapeutic apheresis products, transfusion therapy (Sepacell), and virus removal filters for biopharmaceuticals. Its dialyzers are used in more than 70 countries. The company has a global presence, operating in the U.S., Asia Pacific, Europe, and the MEA. Asahi Kasei Corporation operates through five business units: Asahi Kasei Microdevices Corp., Asahi Kasei Construction Materials Corp., Asahi Kasei Homes Corp., Asahi Kasei Pharma Corp., and Asahi Kasei Medical Co., Ltd.    

• Cantel Medical is a leading healthcare company that delivers innovative infection prevention products, diagnostics, and therapeutic medical equipment. The company's operating segments include medical, life sciences, dental, and dialysis. It offers products such as flexible & rigid endoscopes, microscopes, hemodialysis dialyzer & reprocessing systems, and sterilant & filtration systems. The medical segment functions via MEDIVATORS and Mar Cor Purification, Inc. Its infection prevention products are used mainly in the dental market. Key products include sterilization pouches, face masks, tray covers, germicidal wipes, plastic cups, saliva ejectors, and disinfectants. This segment is operated through Crosstex International, Inc. In addition, the company provides technical services for its products.

• NIKKISO CO. LTD. is a Japan-based global healthcare company that develops, manufactures, and markets various industrial & medical business-related products. The company operates in two business segments. The industrial business segment manufactures and distributes industrial special pumps, liquefied gas, and related equipment & devices. This business is also involved in aerospace and precision equipment. The medical business segment offers dialysis-related products, including hemodialysis & peritoneal dialysis such as dialyzers, artificial dialysis machines, and bloodlines. It also provides products and medicines related to CRRT, artificial pancreas devices, and energy devices for microwave surgery.

• JMS CO. LTD. is a Japan-based healthcare company engaged in the development, manufacture, and commercialization of medical devices & drugs. The company functions through five reportable business segments, including infusion & nutrition, dialysis, surgical treatment, blood management, and cell therapy. Products offered by the company include dialysis products, peritoneal dialysates, syringe pumps, infusion & transfusion sets, surgical gowns, blood bags, and microcatheters. The company has a global presence with manufacturing facilities in the Philippines, Japan, Singapore, China, and Germany.

• Medtronic is a health solutions company engaged in the development, manufacture, distribution, and commercialization of device-based medical therapies & services. It operates through four segments: cardiac & vascular, minimally invasive therapies, restorative therapies, and diabetes. Its cardiac surgery products include positioning and stabilization systems for beating heart revascularization surgery. The company offers innovations in the surgical space involving robotic and automated technologies. Its vascular group offers therapies and products for the treatment of vascular diseases, including coronary, peripheral, and vascular stents. Its products include neurovascular stents, coils, and flow diversion products, as well as access and delivery products to support neuro procedures. The company has a global presence and operates from more than 370 locations in approximately 160 countries. Medtronic’s products are used mainly in surgical centers, hospitals, home care, and long-term care facilities.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

End Stage Renal Disease Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 - 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

End Stage Renal Disease Market Report Assumptions:

• The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.